Scott Isaacs, MD, FACE, FACP and Barton Isaac, PharmD present: NASH Patient Identification, Referral and Management in Endocrinology and Hepatology Practices
Melody.education: Educational programs on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD)
00:00
Understanding NASH Diagnosis and Risk Stratification
This chapter explores methodologies for diagnosing Nonalcoholic Steatohepatitis (NASH), focusing on the significance of the Fib4 score in risk stratification. It highlights the implications of low and high Fib4 scores on patient management and the role of imaging techniques in evaluating liver health.
Transcript
Play full episode
